These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2464906)

  • 1. Heparan sulfate degradation in tumor cell invasion and angiogenesis.
    Vlodavsky I; Eldor A; Bar-Ner M; Fridman R; Cohen IR; Klagsbrun M
    Adv Exp Med Biol; 1988; 233():201-10. PubMed ID: 2464906
    [No Abstract]   [Full Text] [Related]  

  • 2. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
    Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I
    J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
    Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
    Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix heparan sulphate, but not endothelial cell surface heparan sulphate, is degraded by highly metastatic mouse lymphoma cells.
    Hennes R; Frantzen F; Keller R; Schirrmacher V; Schwartz-Albiez R
    Br J Cancer; 1988 Aug; 58(2):186-8. PubMed ID: 2971387
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines.
    Nakajima M; Irimura T; Di Ferrante D; Di Ferrante N; Nicolson GL
    Science; 1983 May; 220(4597):611-3. PubMed ID: 6220468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix.
    Fridman R; Lider O; Naparstek Y; Fuks Z; Vlodavsky I; Cohen IR
    J Cell Physiol; 1987 Jan; 130(1):85-92. PubMed ID: 2433294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for degradation of heparan sulfate by endoglycosidases: glucosamine and hexuronic acid are reducing terminals of intracellular heparan sulfate from human skin fibroblasts.
    Klein U; Kresse H; von Figura K
    Biochem Biophys Res Commun; 1976 Mar; 69(1):158-66. PubMed ID: 130905
    [No Abstract]   [Full Text] [Related]  

  • 8. Differentiating human leukemia cells express heparanase that degrades heparan sulfate in subendothelial extracellular matrix.
    Yahalom J; Fibach E; Bar-Tana R; Fuks Z; Vlodavsky I
    Leuk Res; 1988; 12(9):711-7. PubMed ID: 2973542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix.
    Bashkin P; Razin E; Eldor A; Vlodavsky I
    Blood; 1990 Jun; 75(11):2204-12. PubMed ID: 1693299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A heparan sulfate-degrading endoglycosidase from rat liver tissue.
    Höök M; Wasteson A; Oldberg A
    Biochem Biophys Res Commun; 1975 Dec; 67(4):1422-8. PubMed ID: 1035
    [No Abstract]   [Full Text] [Related]  

  • 11. Binding of interferon-gamma to heparan sulfate is restricted to the heparin-like domains and involves carboxylic--but not N-sulfated--groups.
    Lortat-Jacob H; Grimaud JA
    Biochim Biophys Acta; 1992 Sep; 1117(2):126-30. PubMed ID: 1525174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human heparanase: roles in invasion and metastasis of cancer].
    Gohji K; Katsuoka Y; Okamoto M; Kamidono S; Kitazawa S; Toyoshima M; Dong J; Nakajima M
    Hinyokika Kiyo; 2000 Oct; 46(10):757-62. PubMed ID: 11215206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basement membrane degradative enzymes as possible markers of tumor metastasis.
    Nakajima M; Welch DR; Irimura T; Nicolson GL
    Prog Clin Biol Res; 1986; 212():113-22. PubMed ID: 2940601
    [No Abstract]   [Full Text] [Related]  

  • 14. Neutralization of thrombin by antithrombin III in the presence of cultured human fibroblasts.
    Brandt JT; Stephens RE; Hinkle GH
    Thromb Res; 1988 Jul; 51(2):187-96. PubMed ID: 2973155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
    Marchetti D
    J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate.
    Sewell RF; Brenchley PE; Mallick NP
    Biochem J; 1989 Dec; 264(3):777-83. PubMed ID: 2533499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan structure and the modulation of angiogenesis.
    Long WF; Williamson FB
    Med Hypotheses; 1984 Apr; 13(4):385-94. PubMed ID: 6203020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal degradation of heparin and heparan sulphate.
    Freeman C; Hopwood J
    Adv Exp Med Biol; 1992; 313():121-34. PubMed ID: 1442257
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular characteristics of extracellular matrix-associated glycosaminoglycans in the endothelium.
    Wang ZW; Irimura T; Nakajima M; Belloni PN; Nicolson GL
    Zhongguo Yao Li Xue Bao; 1986 Mar; 7(2):152-6. PubMed ID: 2946155
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research advancement on heparanase in tumor metastasis].
    Li ZH; Yang SM
    Ai Zheng; 2005 Sep; 24(9):1156-60. PubMed ID: 16159446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.